CAPTRUST Financial Advisors
DTIL icon

CAPTRUST Financial Advisors’s Precision BioSciences DTIL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,783
Closed -$41.4K – 2298
2023
Q4 		$41.4K Sell
3,783
-294
-7% -$3.17K ﹤0.01% 2602
2023
Q3 		$41.7K Sell
4,077
-25
-0.6% -$384 ﹤0.01% 2494
2023
Q2 		$64.7K Sell
4,102
-940
-19% -$21.5K ﹤0.01% 2416
2023
Q1 		$114K Sell
5,042
-95
-2% -$3.13K ﹤0.01% 2140
2022
Q4 		$183K Sell
5,137
-4
-0.1% -$158 ﹤0.01% 1962
2022
Q3 		$201K Sell
5,141
-2
-0% -$95 ﹤0.01% 1819
2022
Q2 		$247K Buy
5,143
+44
+0.9% +$2.58K ﹤0.01% 1547
2022
Q1 		$471K Buy
5,099
+137
+3% +$18.6K ﹤0.01% 1177
2021
Q4 		$1.1M Buy
4,962
+93
+2% +$26K 0.01% 777
2021
Q3 		$1.69M Buy
4,869
+4,850
+25,526% +$1.64M 0.01% 566
2021
Q2 		$7K Buy
19
+12
+171% +$3.6K ﹤0.01% 3700
2021
Q1 		$2K Buy
+7
New +$2.45K ﹤0.01% 4027

Other funds holding DTIL

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

CAPTRUST Financial Advisors's DTIL Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 3,783 shares — an estimated $41.4K sold.

CAPTRUST Financial Advisors first reported a position in DTIL in Q1 2021 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,783 Precision BioSciences shares in Q1 2024, an estimated $41.4K.
  • CAPTRUST Financial Advisors first reported a position in Precision BioSciences in Q1 2021 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's Precision BioSciences position peaked at $1.69M in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.